brivaracetam Solution for infusion 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Manufacturer #2346
This pharmaceutical company, based in Europe, has a track record spanning several decades. They offer a diverse product portfolio, including prescription and over-the-counter medications, mainly in solid and liquid dosage forms. They are particularly known for their expertise in lyophilized products. The company has achieved global reach through licensing, exports, and third-party manufacturing agreements, with a strong presence in Europe, North America, and emerging markets in the Middle East, Latin America, and Asia Pacific. Their manufacturing facilities adhere to strict European and international Good Manufacturing Practices (GMP) standards. Key focus areas include generic pharmaceuticals and technology transfer services for third-party products.

Manufacturer usually replies in 33 days